Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Russia

IronPort Uncovers Illicit Online Pharmaceutical Business

June 2008 | Industry News

The prevalence and prevention of counterfeit pharmaceuticals is a highly publicised topic, both in Europe and globally. There have been widely varying figures of the estimated value and volume of this illegal trade, with Pfizer claiming that it is losing US$2bn a year in sales through counterfeits of its anti-impotence drug Viagra (sildenafil) alone. While it is difficult accurately to measure the true value of the global counterfeit market, what is clear is that there is a significant problem and that the internet is a major source of counterfeit

To read the full article, please choose one of the following options:

Subcribers please log in

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries